Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. (Q54288930)

27 May 2018

title

Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. (English)

1 reference

27 May 2018

1 reference

13

1 reference

27 May 2018

Zhixin Qiu

object named as

Zhixin Qiu

4

0 references

Kurt Zatloukal

11

object named as

Kurt Zatloukal

1 reference

27 May 2018

author name string

Lihua Min

1

1 reference

27 May 2018

Yuan Ji

2

1 reference

27 May 2018

Latifa Bakiri

3

1 reference

27 May 2018

Jin Cen

5

1 reference

27 May 2018

Xiaotao Chen

6

1 reference

27 May 2018

Lingli Chen

7

1 reference

27 May 2018

Harald Scheuch

8

1 reference

27 May 2018

Hai Zheng

9

1 reference

27 May 2018

Lunxiu Qin

10

1 reference

27 May 2018

Lijian Hui

12

1 reference

27 May 2018

publication date

7 October 2012

1 reference

27 May 2018

published in

Nature Cell Biology

1 reference

27 May 2018

volume

14

1 reference

27 May 2018

issue

11

1 reference

27 May 2018

page(s)

1203-1211

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1038/ncb2590

exact match

0 references

cites work

Fos and jun proteins are specifically expressed during differentiation of human keratinocytes

1 reference

12 December 2020

Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation

1 reference

12 December 2020

Emerging roles of ATF2 and the dynamic AP1 network in cancer

1 reference

12 December 2020

Hepatocyte survival in acute hepatitis is due to c-Jun/AP-1-dependent expression of inducible nitric oxide synthase

1 reference

12 December 2020

Survivin, cancer networks and pathway-directed drug discovery.

1 reference

12 December 2020

Histological patterns in drug-induced liver disease

1 reference

12 December 2020

Complex formation of Plk1 and INCENP required for metaphase-anaphase transition

1 reference

12 December 2020

SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin

1 reference

12 December 2020

Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation

1 reference

12 December 2020

Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis

1 reference

12 December 2020

Stage-specific sensitivity to p53 restoration during lung cancer progression.

1 reference

12 December 2020

The role of JNK in the development of hepatocellular carcinoma

1 reference

12 December 2020

AP-1: a double-edged sword in tumorigenesis

1 reference

12 December 2020

Cancer prevention: major initiatives and looking into the future

1 reference

12 December 2020

Mouse models of hepatocellular carcinoma

1 reference

12 December 2020

Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia

1 reference

12 December 2020

IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis

1 reference

12 December 2020

Hallmarks of Cancer: The Next Generation

1 reference

12 December 2020

Hepatocellular carcinoma pathogenesis: from genes to environment

1 reference

12 December 2020

A limited role for p53 in modulating the immediate phenotype of Apc loss in the intestine

1 reference

12 December 2020

Activation of NF-kappa B, AP-1 and STAT transcription factors is a frequent and early event in human hepatocellular carcinomas

1 reference

12 December 2020

Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia

1 reference

12 December 2020

The pathological response to DNA damage does not contribute to p53-mediated tumour suppression

1 reference

12 December 2020

Selective activation of p53-mediated tumour suppression in high-grade tumours

1 reference

12 December 2020

SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span

1 reference

12 December 2020

p38α suppresses normal and cancer cell proliferation by antagonizing the JNK–c-Jun pathway

1 reference

12 December 2020

Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis

1 reference

12 December 2020

Prevention of recurrence after resection of hepatocellular carcinoma: a daunting challenge

1 reference

12 December 2020

Jun and JunD-dependent functions in cell proliferation and stress response.

1 reference

12 December 2020

Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53

1 reference

12 December 2020

Hepatocyte-specific expression of Cre recombinase

1 reference

12 December 2020

The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis.

1 reference

12 December 2020

Rhabdomyosarcoma development in mice lacking Trp53 and Fos

1 reference

12 December 2020

A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells.

1 reference

12 December 2020

Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats

1 reference

12 December 2020

Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis

1 reference

12 December 2020

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

1 reference

12 December 2020

Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression

1 reference

12 December 2020

Cancer gene therapy using a survivin mutant adenovirus

1 reference

12 December 2020

Survivin gene expression in chronic liver disease and hepatocellular carcinoma.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NCB2590

1 reference

27 May 2018

PubMed ID

23041974

1 reference

27 May 2018